Immune
Boston, US · Founded 2023 · Delaware corporation · 1 known investors
Founders & leadership
AT
Ariana ThackerNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 2 rounds · 2025
▶$6.4MraisedFeb 2025 · 13 investors · Other TechnologyRule 506(b)
▶$6.4MraisedFeb 2025 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ariana ThackerExecutive Officer
- Offering amount
- $7M
- Amount sold
- $6.4M
- Minimum investment
- $998
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1MraisedFeb 2025 · 6 investors · Other TechnologyRule 506(b)
▶$1MraisedFeb 2025 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ariana ThackerExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Immune's investors?
- Immune's investors include BioAdvance.
- How much funding has Immune raised?
- Immune has disclosed $7.4M raised across 2 rounds.
- Where is Immune headquartered?
- Immune is headquartered in Boston, US.